Evidence map›Paper›PMID 41848891›Full record

ArticleBioprocess and biosystems engineering2026

Data-efficient hybrid parameter scaling for accurate microbial bioreactor scale-up.

Otabek Atabaev, Moulay Rachid Babaa

Abstract read
PubMed Publisher
In one paragraph

Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Otabek AtabaevDepartment of Chemical Engineering, New Uzbekistan University, 100007, Tashkent, Uzbekistan.
Moulay Rachid BabaaDepartment of Chemical Engineering, New Uzbekistan University, 100007, Tashkent, Uzbekistan. m.babaa@newuu.uz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurately predicting microbial fermentation performance at an industrial scale is challenging due to hydrodynamic and oxygen-transfer limitations, which disrupt geometric similarity and cause nonlinear changes in apparent production kinetics. The goal of this work is to develop a data-efficient hybrid scaling law that extrapolates time-course model parameters of relative lipase concentration across bioreactor volumes using minimal experimental scales. Sigmoidal lipase accumulation curves from 10 L, 100 L, 4 m³, and 100 m³ bioreactors were extracted from the study of Geraats (1994) and fitted using Logistic, Gompertz, and Baranyi–Roberts (BR) models. Kinetic parameters (Lmax, k or µ, tmid or λ) obtained from small-scale bioreactors (10 L and 100 L) were used to construct two minimal two-point relations: power-law and logarithmic. As these relations showed systematic overshoot and undershoot during extrapolation, a hybrid convex-weighting scheme was developed and calibrated at the 4 m³ pilot scale. When applied to the 100 m³ industrial dataset, the hybrid method significantly improved prediction accuracy compared to either scaling law alone, reducing RMSE by more than 60%. The Baranyi–Roberts model combined with hybrid scaling achieved the highest overall accuracy (RMSE = 2.651). Requiring only three experimental scales, this approach is computationally efficient, mechanistically interpretable, and suitable for industrial contexts where extensive pilot campaigns or computational fluid dynamics simulations are not feasible. The hybrid scaling framework thus offers a practical and data-efficient solution for reliable bioreactor scale-up.

Indexed as

BioreactorsLipaseModels, BiologicalFermentationKineticsLipaseBioprocess scale-upHybrid scalingIndustrial fermentation.Microbial kineticsSigmoidal models

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.